Accordingly, glutamine consumption, α-KG production, and ATP levels were dramatically decreased by TUG1 knockdown in ICC cells, and this effect was reversed by miR-145 inhibition. The gene discussed is TUG1; the disease is intrahepatic cholangiocarcinoma.